Legal & General Group Plc - OCULAR THERAPEUTIX INC ownership

OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 114 filers reported holding OCULAR THERAPEUTIX INC in Q3 2023. The put-call ratio across all filers is 0.46 and the average weighting 0.9%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of OCULAR THERAPEUTIX INC
ValueSharesWeighting
Q3 2023$27,975
-43.7%
8,909
-7.5%
0.00%
Q2 2023$49,712
+1.3%
9,634
+3.5%
0.00%
Q1 2023$49,053
+96.8%
9,308
+4.9%
0.00%
Q4 2022$24,922
-32.6%
8,8690.0%0.00%
Q3 2022$37,0000.0%8,869
-4.1%
0.00%
Q2 2022$37,000
-86.0%
9,251
-82.7%
0.00%
Q1 2022$265,000
-29.1%
53,5500.0%0.00%
Q4 2021$374,000
+9.7%
53,550
+57.3%
0.00%
Q3 2021$341,000
+11.8%
34,052
+58.2%
0.00%
Q2 2021$305,000
-12.9%
21,519
+0.8%
0.00%
Q1 2021$350,000
-21.3%
21,346
-0.5%
0.00%
Q4 2020$445,000
+709.1%
21,460
+197.4%
0.00%
Q3 2020$55,000
-21.4%
7,217
-14.6%
0.00%
Q2 2020$70,000
+105.9%
8,454
+24.2%
0.00%
Q1 2020$34,000
+3.0%
6,805
-18.6%
0.00%
Q4 2019$33,000
+65.0%
8,359
+25.2%
0.00%
Q3 2019$20,000
-31.0%
6,6770.0%0.00%
Q2 2019$29,000
+7.4%
6,6770.0%0.00%
Q1 2019$27,000
+42.1%
6,677
+37.9%
0.00%
Q4 2018$19,000
-42.4%
4,8420.0%0.00%
Q3 2018$33,0000.0%4,8420.0%0.00%
Q2 2018$33,0000.0%4,842
-4.7%
0.00%
Q1 2018$33,000
+22.2%
5,083
-14.9%
0.00%
Q4 2017$27,000
-28.9%
5,9750.0%0.00%
Q3 2017$38,000
-30.9%
5,9750.0%0.00%
Q2 2017$55,000
+96.4%
5,975
+96.2%
0.00%
Q1 2017$28,000
+12.0%
3,0450.0%0.00%
Q4 2016$25,0003,0450.00%
Other shareholders
OCULAR THERAPEUTIX INC shareholders Q3 2023
NameSharesValueWeighting ↓
SUMMER ROAD LLC 6,122,089$32,263100.00%
Opaleye Management Inc. 6,105,900$32,178,0939.64%
DELTEC ASSET MANAGEMENT LLC 1,913,612$10,084,7352.49%
Knoll Capital Management, LLC 200,000$1,504,0002.32%
Endurant Capital Management LP 512,744$2,702,1611.39%
Knoll Capital Management, LLC 95,800$504,8660.78%
Covestor Ltd 60,008$3160.28%
Ikarian Capital, LLC 200,000$1,054,0000.24%
EAM Investors, LLC 224,211$1,181,5920.23%
Nebula Research & Development LLC 22,474$118,4380.21%
View complete list of OCULAR THERAPEUTIX INC shareholders